drugset / Trial / NCT05258565
TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients
Non-randomizedSequentialTriple-blindTreatment
Summary
The investigator will recruit consecutively all patients coming with acute ischemic stroke either with or without COVID -19 infection and suitable for IV injection with Tissue plasminogen activators according to guideline and inclusion criteria of tPA. Aswan University Hospital.
Timeline
- Start
- 2022-03-01
- Primary completion
- 2022-06-15
- Completion
- 2022-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alteplase | Protein / enzyme biologic | 0.9 mg/kg | Intravenous |